MBCYX
Price
$26.41
Change
-$0.16 (-0.60%)
Updated
Oct 7 closing price
Net Assets
2.19B
RGACX
Price
$85.45
Change
-$0.56 (-0.65%)
Updated
Oct 7 closing price
Net Assets
342.85B
Interact to see
Advertisement

MBCYX vs RGACX

Header iconMBCYX vs RGACX Comparison
Open Charts MBCYX vs RGACXBanner chart's image
MassMutual Blue Chip Growth Svc
Price$26.41
Change-$0.16 (-0.60%)
VolumeN/A
Net Assets2.19B
American Funds Growth Fund of Amer R3
Price$85.45
Change-$0.56 (-0.65%)
VolumeN/A
Net Assets342.85B
MBCYX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
MBCYX vs. RGACX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBCYX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 343B vs. MBCYX (2.19B). RGACX pays higher dividends than MBCYX: RGACX (0.07) vs MBCYX (0.00). MBCYX was incepted earlier than RGACX: MBCYX (24 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than MBCYX (0.85). RGACX is a more actively managed with annual turnover of: 25.00 vs. MBCYX (11.00). RGACX has a lower initial minimum investment than MBCYX: RGACX (250) vs MBCYX (1000). MBCYX annual gain was more profitable for investors over the last year : 24.86 vs. RGACX (14.51). RGACX return over 5 years is better than : 40.62 vs. MBCYX (-9.02).
MBCYXRGACXMBCYX / RGACX
Total Expense Ratio0.850.9490%
Annual Report Gross Expense Ratio0.850.9490%
Fund Existence24 years23 years-
Gain YTD16.89418.69790%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.19B343B1%
Annual Yield % from dividends0.000.07-
Returns for 1 year24.8614.51171%
Returns for 3 years43.1772.9859%
Returns for 5 years-9.0240.62-22%
Returns for 10 years51.2499.8251%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHSRX53.080.05
+0.09%
Putnam Global Health Care R
BNIEX12.40N/A
N/A
UBS International Sustainable Equity A
FEYTX30.55N/A
N/A
Fidelity Advisor Asset Manager 85% M
TSWMX11.92N/A
N/A
TSW Emerging Markets Institutional
GCSAX29.55N/A
N/A
Goldman Sachs Small Cap Eq Insghts A